Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-05 02:16 | 2021-12-30 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Laboratory Analytical Instruments | SALE | $150.38 | 1,500 | $225,569 | 3,000 | -33.3% |
| 2021-11-30 02:14 | 2021-11-24 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Laboratory Analytical Instruments | SALE | $150.06 | 1,500 | $225,084 | 4,500 | -25.0% |
| 2021-10-28 00:19 | 2021-10-25 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Laboratory Analytical Instruments | SALE | $166.32 | 1,500 | $249,478 | 6,000 | -20.0% |
| 2021-09-25 01:37 | 2021-09-23 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Laboratory Analytical Instruments | SALE | $159.04 | 1,500 | $238,562 | 7,500 | -16.7% |
| 2021-08-26 03:39 | 2021-08-23 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Laboratory Analytical Instruments | SALE | $162.06 | 1,500 | $243,087 | 9,000 | -14.3% |
| 2021-07-26 23:35 | 2021-07-23 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Laboratory Analytical Instruments | SALE | $183.67 | 1,500 | $275,500 | 10,500 | -12.5% |
| 2021-06-25 23:23 | 2021-06-23 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Laboratory Analytical Instruments | SALE | $199.95 | 1,500 | $299,923 | 12,000 | -11.1% |
| 2021-05-27 03:28 | 2021-05-24 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Laboratory Analytical Instruments | SALE | $161.16 | 1,500 | $241,746 | 13,500 | -10.0% |
| 2021-04-28 00:58 | 2021-04-23 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Laboratory Analytical Instruments | SALE | $193.08 | 1,500 | $289,623 | 15,000 | -9.1% |
| 2021-03-26 03:32 | 2021-03-23 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | Laboratory Analytical Instruments | SALE | $174.63 | 1,500 | $261,939 | 16,500 | -8.3% |
| 2020-04-18 04:08 | 2020-04-15 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; President | Surgical & Medical Instruments & Apparatus | SALE | $169.28 | 2,500 | $423,204 | 155,351 | -1.6% |
| 2020-03-19 02:55 | 2020-03-16 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; President | Surgical & Medical Instruments & Apparatus | SALE | $154.36 | 2,500 | $385,901 | 157,851 | -1.6% |
| 2020-02-21 04:03 | 2020-02-18 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; President | Surgical & Medical Instruments & Apparatus | SALE | $190.70 | 2,500 | $476,761 | 160,351 | -1.5% |
| 2020-02-04 04:18 | 2020-01-30 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; President | Surgical & Medical Instruments & Apparatus | SALE | $176.15 | 2,500 | $440,373 | 163,851 | -1.5% |
| 2019-08-03 03:09 | 2019-08-01 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $169.36 | 5,000 | $846,824 | 166,351 | -2.9% |
| 2019-07-04 02:30 | 2019-07-01 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $159.96 | 5,000 | $799,802 | 171,351 | -2.8% |
| 2019-06-06 03:37 | 2019-06-03 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $142.89 | 5,000 | $714,461 | 176,351 | -2.8% |
| 2019-05-04 02:22 | 2019-05-01 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $130.25 | 5,000 | $651,226 | 182,351 | -2.7% |
| 2019-04-04 01:52 | 2019-04-01 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $143.45 | 5,000 | $717,251 | 115,750 | -4.1% |
| 2019-03-14 01:15 | 2019-03-11 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $139.84 | 5,000 | $699,220 | 120,750 | -4.0% |
| 2017-11-30 04:07 | 2017-11-27 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $103.83 | 6,026 | $625,691 | 55,147 | -9.9% |
| 2017-11-28 03:44 | 2017-11-22 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $105.10 | 4,818 | $506,388 | 61,173 | -7.3% |
| 2017-11-23 00:10 | 2017-11-21 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $107.29 | 6,300 | $675,899 | 65,991 | -8.7% |
| 2017-11-21 04:32 | 2017-11-16 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $105.27 | 21,956 | $2,311,352 | 72,291 | -23.3% |
| 2017-11-17 02:42 | 2017-11-14 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $105.89 | 10,900 | $1,154,162 | 94,247 | -10.4% |
| 2017-02-15 02:47 | 2017-02-13 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $72.94 | 1,600 | $116,708 | 489,607 | -0.3% |
| 2017-02-11 03:25 | 2017-02-08 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $71.49 | 15,500 | $1,108,132 | 491,207 | -3.1% |
| 2017-02-09 05:17 | 2017-02-06 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $70.00 | 100 | $7,000 | 506,707 | 0.0% |
| 2017-02-04 04:16 | 2017-02-01 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $70.56 | 7,800 | $550,349 | 506,807 | -1.5% |
| 2016-11-18 03:29 | 2016-11-15 | PEN | Penumbra Inc | Kosaraju Sridhar | Officer; CFO and Head of Strategy | Surgical & Medical Instruments & Apparatus | SALE | $65.07 | 25,000 | $1,626,798 | 514,607 | -4.6% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.